Our mission is to end the threat of age-related disease for this and future generations
We believe it is possible for people to enjoy their lives at 95 as much as they do at 25, and to achieve that, we’re seeking a more comprehensive understanding of the biology of aging itself.
Advancing the frontiers
of aging research
Using cutting-edge science to tackle aging, the #1 risk factor for chronic disease.
First patient treated with drug based on Buck research
Geriatrician-scientist John Newman, MD, PhD, joins the Buck faculty
Largest “pan-cancer” genomics study spurs future efforts to enroll patients in specialized “basket” clinical trials
Here’s what’s happening
Upcoming events that feature Buck science